Chondroitin Sulfate for Cartilage Regeneration, Administered Topically Using a Nanostructured Formulation.
Ontology highlight
ABSTRACT: In the pharmaceutical sector, solid lipid nanoparticles (SLN) are vital for drug delivery incorporating a lipid core. Chondroitin sulfate (CHON) is crucial for cartilage health. It is often used in osteoarthritis (OA) treatment. Due to conflicting results from clinical trials on CHON's efficacy in OA treatment, there has been a shift toward exploring effective topical systems utilizing nanotechnology. This study aimed to optimize a solid lipid nanoparticle formulation aiming to enhance CHON permeation for OA therapy. A 3 × 3 × 2 Design of these experiments determined the ideal parameters: a CHON concentration of 0.4 mg/mL, operating at 20,000 rpm speed, and processing for 10 min for SLN production. Transmission electron microscopy analysis confirmed the nanoparticles' spherical morphology,
SUBMITTER: Bustos Araya ME
PROVIDER: S-EPMC11432425 | biostudies-literature | 2024 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA